Aralez Pharmaceuticals Inc. Opens the Market

TORONTO, April 5, 2016 /CNW/ - Adrian Adams, CEO, Aralez Pharmaceuticals Inc. (ARZ), joined Loui Anastasopoulos, Vice President, TSX Company Services, Toronto Stock Exchange & TSX Venture Exchange to open the market. Headquartered in Ontario, Canada Aralez Pharmaceuticals is a global specialty pharmaceutical focused on the acquisition, development and commercialization of products primarily in cardiovascular, pain and other specialty areas. Aralez Pharmaceuticals Inc. graduated from TSX Venture Exchange and commenced trading on Toronto Stock Exchange on February 9, 2016. Aralez Pharmaceuticals was the second-best performing company in the Clean Technology & Life Sciences sector on the 2016 TSX Venture 50. For more information, please visit www.aralez.com.

SOURCE TMX Group Limited

Image with caption: "Adrian Adams, CEO, Aralez Pharmaceuticals Inc. (ARZ), joined Loui Anastasopoulos, Vice President, TSX Company Services, Toronto Stock Exchange & TSX Venture Exchange to open the market. Headquartered in Ontario, Canada Aralez Pharmaceuticals is a global specialty pharmaceutical focused on the acquisition, development and commercialization of products primarily in cardiovascular, pain and other specialty areas. Aralez Pharmaceuticals Inc. graduated from TSX Venture Exchange and commenced trading on Toronto Stock Exchange on February 9, 2016. Aralez Pharmaceuticals was the second-best performing company in the Clean Technology & Life Sciences sector on the 2016 TSX Venture 50. For more information, please visit www.aralez.com. (CNW Group/TMX Group Limited)". Image available at: http://photos.newswire.ca/images/download/20160405_C1540_PHOTO_EN_658077.jpg

For further information: please visit www.aralez.com.


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890